Skip to main content
Top
Published in: Journal of Neural Transmission 12/2012

01-12-2012 | Dementias - Original Article

Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders

Authors: Richard A. Armstrong, Nigel J. Cairns

Published in: Journal of Neural Transmission | Issue 12/2012

Login to get access

Abstract

Recent research suggests cell-to-cell transfer of pathogenic proteins such as tau and α-synuclein may play a role in neurodegeneration. Pathogenic spread along neural pathways may give rise to specific spatial patterns of the neuronal cytoplasmic inclusions (NCI) characteristic of these disorders. Hence, the spatial patterns of NCI were compared in four tauopathies, viz., Alzheimer’s disease, Pick’s disease, corticobasal degeneration, and progressive supranuclear palsy, two synucleinopathies, viz., dementia with Lewy bodies and multiple system atrophy, the ‘fused in sarcoma’ (FUS)-immunoreactive inclusions in neuronal intermediate filament inclusion disease, and the transactive response DNA-binding protein (TDP-43)-immunoreactive inclusions in frontotemporal lobar degeneration, a TDP-43 proteinopathy (FTLD-TDP). Regardless of molecular group or morphology, NCI were most frequently aggregated into clusters, the clusters being regularly distributed parallel to the pia mater. In a significant proportion of regions, the regularly distributed clusters were in the size range 400–800 μm, approximating to the dimension of cell columns associated with the cortico-cortical pathways. The data suggest that cortical NCI in different disorders exhibit a similar spatial pattern in the cortex consistent with pathogenic spread along anatomical pathways. Hence, treatments designed to protect the cortex from neurodegeneration may be applicable across several different disorders.
Literature
go back to reference Armstrong RA (1993a) Is the clustering of neurofibrillary tangles in Alzheimer’s patients related to the cells of origin of specific cortico-cortical projections? Neurosci Lett 160:57–60PubMedCrossRef Armstrong RA (1993a) Is the clustering of neurofibrillary tangles in Alzheimer’s patients related to the cells of origin of specific cortico-cortical projections? Neurosci Lett 160:57–60PubMedCrossRef
go back to reference Armstrong RA (1993b) The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with special reference to plaque formation in Alzheimer’s disease. Neurodegeneration 2:73–80 Armstrong RA (1993b) The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with special reference to plaque formation in Alzheimer’s disease. Neurodegeneration 2:73–80
go back to reference Armstrong RA (1997) Analysis of spatial patterns in histological sections of brain tissue. J Neurosci Methods 73:141–147PubMedCrossRef Armstrong RA (1997) Analysis of spatial patterns in histological sections of brain tissue. J Neurosci Methods 73:141–147PubMedCrossRef
go back to reference Armstrong RA (2003) Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology 42:521–529PubMedCrossRef Armstrong RA (2003) Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology 42:521–529PubMedCrossRef
go back to reference Armstrong RA (2006) Methods of studying the planar distribution of objects in histological sections of brain tissue. J Microsc (Oxf) 221:153–158CrossRef Armstrong RA (2006) Methods of studying the planar distribution of objects in histological sections of brain tissue. J Microsc (Oxf) 221:153–158CrossRef
go back to reference Armstrong RA (2007) Measuring the spatial arrangement patterns of pathological lesions in histological sections of brain tissue. Folia Neuropathol 44:229–237 Armstrong RA (2007) Measuring the spatial arrangement patterns of pathological lesions in histological sections of brain tissue. Folia Neuropathol 44:229–237
go back to reference Armstrong RA (2008) Clustering and periodicity of neurofibrillary tangles in the upper and lower cortical laminae in Alzheimer’s disease. Folia Neuropathol 46:26–31PubMed Armstrong RA (2008) Clustering and periodicity of neurofibrillary tangles in the upper and lower cortical laminae in Alzheimer’s disease. Folia Neuropathol 46:26–31PubMed
go back to reference Armstrong RA (2009a) Quantitative methods in neuropathology. Folia Neuropathol 48:217–230 Armstrong RA (2009a) Quantitative methods in neuropathology. Folia Neuropathol 48:217–230
go back to reference Armstrong RA (2009b) The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol 47:289–299PubMed Armstrong RA (2009b) The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol 47:289–299PubMed
go back to reference Armstrong RA, Cairns NJ (2009) Clustering and spatial correlations of the neuronal cytoplasmic inclusions, astrocytic plaques and ballooned neurons in corticobasal degeneration. J Neural Transm 116:1103–1110PubMedCrossRef Armstrong RA, Cairns NJ (2009) Clustering and spatial correlations of the neuronal cytoplasmic inclusions, astrocytic plaques and ballooned neurons in corticobasal degeneration. J Neural Transm 116:1103–1110PubMedCrossRef
go back to reference Armstrong RA, Cairns NJ, Lantos PL (1997) Dementia with Lewy bodies: clustering of Lewy bodies in human patients. Neurosci Lett 224:41–44PubMedCrossRef Armstrong RA, Cairns NJ, Lantos PL (1997) Dementia with Lewy bodies: clustering of Lewy bodies in human patients. Neurosci Lett 224:41–44PubMedCrossRef
go back to reference Armstrong RA, Cairns NJ, Lantos PL (1998) Clustering of Pick bodies in cases of Pick’s disease. Neurosci Lett 242:81–84PubMedCrossRef Armstrong RA, Cairns NJ, Lantos PL (1998) Clustering of Pick bodies in cases of Pick’s disease. Neurosci Lett 242:81–84PubMedCrossRef
go back to reference Armstrong RA, Lantos PL, Cairns NJ (2001) What does the study of spatial patterns of pathological lesions tell us about the pathogenesis of neurodegerative disorders. Neuropathology 21:1–12PubMedCrossRef Armstrong RA, Lantos PL, Cairns NJ (2001) What does the study of spatial patterns of pathological lesions tell us about the pathogenesis of neurodegerative disorders. Neuropathology 21:1–12PubMedCrossRef
go back to reference Armstrong RA, Cairns NJ, Lantos PL (2002) Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? Neuropathology 22:114–127CrossRef Armstrong RA, Cairns NJ, Lantos PL (2002) Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? Neuropathology 22:114–127CrossRef
go back to reference Armstrong RA, Cairns NJ, Lantos PL (2006a) Multiple system atrophy: topographic distribution of the α-synuclein associated pathological changes. Parkinsonism Rel Disord 12:356–362CrossRef Armstrong RA, Cairns NJ, Lantos PL (2006a) Multiple system atrophy: topographic distribution of the α-synuclein associated pathological changes. Parkinsonism Rel Disord 12:356–362CrossRef
go back to reference Armstrong RA, Kerty E, Skullerud K, Cairns NJ (2006b) Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using α-internexin immunohistochemistry and principal components analysis (PCA). J Neural Transm 113:1207–1215PubMedCrossRef Armstrong RA, Kerty E, Skullerud K, Cairns NJ (2006b) Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using α-internexin immunohistochemistry and principal components analysis (PCA). J Neural Transm 113:1207–1215PubMedCrossRef
go back to reference Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinsonism Rel Disord 13:50–54CrossRef Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinsonism Rel Disord 13:50–54CrossRef
go back to reference Armstrong RA, Lantos PL, Cairns NJ (2008) What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology 28:351–365PubMedCrossRef Armstrong RA, Lantos PL, Cairns NJ (2008) What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology 28:351–365PubMedCrossRef
go back to reference Armstrong RA, Ellis W, Hamilton RL, Mackenzie IRA, Hedreen J, Gearing M, Montine T, Vonsattel J-P, Head E, Lieberman AP, Cairns NJ (2010) Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 117:227–239PubMedCrossRef Armstrong RA, Ellis W, Hamilton RL, Mackenzie IRA, Hedreen J, Gearing M, Montine T, Vonsattel J-P, Head E, Lieberman AP, Cairns NJ (2010) Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 117:227–239PubMedCrossRef
go back to reference Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IRA, Perry RH, Skullerud K, Yokoo H, Cairns NJ (2011a) The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathol 121:219–228PubMedCrossRef Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IRA, Perry RH, Skullerud K, Yokoo H, Cairns NJ (2011a) The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathol 121:219–228PubMedCrossRef
go back to reference Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IRA, Perry RH, Skullerud K, Yokoo H, Cairns NJ (2011b) Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease. J Neural Transm 118:1651–1657PubMedCrossRef Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IRA, Perry RH, Skullerud K, Yokoo H, Cairns NJ (2011b) Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease. J Neural Transm 118:1651–1657PubMedCrossRef
go back to reference Bigio EH, Brown DF, White CL (1999) Progressive supranuclear palsy with dementia: cortical pathology. J Neuropath Exp Neurol 58:359–364PubMedCrossRef Bigio EH, Brown DF, White CL (1999) Progressive supranuclear palsy with dementia: cortical pathology. J Neuropath Exp Neurol 58:359–364PubMedCrossRef
go back to reference Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134PubMedCrossRef Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134PubMedCrossRef
go back to reference Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCrossRef Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCrossRef
go back to reference Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VMY, Trojanowski JQ (2004a) α-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 164:2153–2161PubMedCrossRef Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VMY, Trojanowski JQ (2004a) α-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 164:2153–2161PubMedCrossRef
go back to reference Cairns NJ, Jaros E, Perry RH, Armstrong RA (2004b) Temporal lobe pathology of human patients with neurofilament inclusion disease. Neurosci Lett 354:245–247PubMedCrossRef Cairns NJ, Jaros E, Perry RH, Armstrong RA (2004b) Temporal lobe pathology of human patients with neurofilament inclusion disease. Neurosci Lett 354:245–247PubMedCrossRef
go back to reference Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM-Y, Trojanowski JQ (2004c) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID). Neurology 63:1376–1384PubMedCrossRef Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM-Y, Trojanowski JQ (2004c) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID). Neurology 63:1376–1384PubMedCrossRef
go back to reference Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, White CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DMA (2007) Neuropathologic diagnostic and nosological criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22PubMedCrossRef Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, White CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DMA (2007) Neuropathologic diagnostic and nosological criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22PubMedCrossRef
go back to reference Davidson Y, Kelley T, Mackenzie IRA, Pickering Brown S, Du Plessis D, Neary D, Snowden JS, Mann DMA (2007) Ubiquinated pathological lesions in frontotemporal lobar degeneration contain TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533PubMedCrossRef Davidson Y, Kelley T, Mackenzie IRA, Pickering Brown S, Du Plessis D, Neary D, Snowden JS, Mann DMA (2007) Ubiquinated pathological lesions in frontotemporal lobar degeneration contain TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533PubMedCrossRef
go back to reference De Lacoste M, White CL (1993) The role of cortical connectivity in Alzheimer’s disease pathogenesis: a review and model system. Neurobiol Aging 14:1–16PubMedCrossRef De Lacoste M, White CL (1993) The role of cortical connectivity in Alzheimer’s disease pathogenesis: a review and model system. Neurobiol Aging 14:1–16PubMedCrossRef
go back to reference Dickson DW (1999) Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Supp 2):6–15CrossRef Dickson DW (1999) Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Supp 2):6–15CrossRef
go back to reference Forman MS, Trojanowski JQ, Lee VM-Y (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055–1063PubMedCrossRef Forman MS, Trojanowski JQ, Lee VM-Y (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055–1063PubMedCrossRef
go back to reference Gilman S, Low PA, Quinn N, Albanese A, Ben-Schlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Roberstson D, Schatz I, Wenning GK (1998) Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 74:189–192PubMed Gilman S, Low PA, Quinn N, Albanese A, Ben-Schlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Roberstson D, Schatz I, Wenning GK (1998) Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 74:189–192PubMed
go back to reference Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA (2001) From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Phil Trans Roy Soc (Lond) B Biol Sci 356:213–227CrossRef Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA (2001) From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Phil Trans Roy Soc (Lond) B Biol Sci 356:213–227CrossRef
go back to reference Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317–325PubMedCrossRef Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317–325PubMedCrossRef
go back to reference Hardy J, Gwinn-Hardy K (1998) Genetic classification of primary neurodegenerative disease. Science 282:1075–1079PubMedCrossRef Hardy J, Gwinn-Hardy K (1998) Genetic classification of primary neurodegenerative disease. Science 282:1075–1079PubMedCrossRef
go back to reference Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (PSP). Neurology 44:2015–2019PubMedCrossRef Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (PSP). Neurology 44:2015–2019PubMedCrossRef
go back to reference Hawkes CH, Del Tredici K, Braak H (2007) Parkinson’s disease: a dual hit hypothesis. Neuropathol Appl Neurobiol 33:599–614PubMedCrossRef Hawkes CH, Del Tredici K, Braak H (2007) Parkinson’s disease: a dual hit hypothesis. Neuropathol Appl Neurobiol 33:599–614PubMedCrossRef
go back to reference Hiorns RW, Neal JW, Pearson RCA, Powell TPS (1991) Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc Roy Soc (Lond) 246:1–9CrossRef Hiorns RW, Neal JW, Pearson RCA, Powell TPS (1991) Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc Roy Soc (Lond) 246:1–9CrossRef
go back to reference Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Davoisen RC, Goetz CG, Golbe LI, Grafman J, Growden JH, Hallett M, Jankovic J, Quinn NP, Tolisa E, Zee DS, Chase TW, FitzGibbon EJ, Hall Z, Juncos J, Nelson KB, Oliver E, Pramstaller P, Reich SG, Verny M (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 47:1–9PubMedCrossRef Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Davoisen RC, Goetz CG, Golbe LI, Grafman J, Growden JH, Hallett M, Jankovic J, Quinn NP, Tolisa E, Zee DS, Chase TW, FitzGibbon EJ, Hall Z, Juncos J, Nelson KB, Oliver E, Pramstaller P, Reich SG, Verny M (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 47:1–9PubMedCrossRef
go back to reference McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardosn JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMedCrossRef McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardosn JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMedCrossRef
go back to reference Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedCrossRef Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedCrossRef
go back to reference Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MW, Lees AJ, Lantos PL, Hutton M (2002) Analysis of tau haplotypes in Pick’s disease. Neurology 59:443–445PubMedCrossRef Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MW, Lees AJ, Lantos PL, Hutton M (2002) Analysis of tau haplotypes in Pick’s disease. Neurology 59:443–445PubMedCrossRef
go back to reference Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, grossman M, Clarke CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldmen H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VMY (2006) Ubiquinated TDP-43 in frontotemporal lobar degeneration and amylotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, grossman M, Clarke CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldmen H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VMY (2006) Ubiquinated TDP-43 in frontotemporal lobar degeneration and amylotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef
go back to reference Neumann M, Roeher S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA (2009) Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease (NIFID). Acta Neuropathol 118:605–616PubMedCrossRef Neumann M, Roeher S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA (2009) Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease (NIFID). Acta Neuropathol 118:605–616PubMedCrossRef
go back to reference Reed LA, Wszolek ZK, Hutton M (2001) Phenotypic correlates in FTDP-17. Neuropathol Aging 22:89–107CrossRef Reed LA, Wszolek ZK, Hutton M (2001) Phenotypic correlates in FTDP-17. Neuropathol Aging 22:89–107CrossRef
go back to reference Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Marayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911–918PubMed Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Marayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911–918PubMed
go back to reference Steiner JA, Angot E, Brunden P (2011) A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ 18:1425–1433PubMedCrossRef Steiner JA, Angot E, Brunden P (2011) A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ 18:1425–1433PubMedCrossRef
go back to reference Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease. Neurology 38:359–364PubMedCrossRef Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease. Neurology 38:359–364PubMedCrossRef
go back to reference Villoslada P, Melero I, Pablus JL, Martino G, Ucelli A, Montalban Y, Avila J, Rivest S, Acarin L, Appel S, Khoury SJ, McGeer P, Ferrer I, Delgado M, Obeso J, Schwartz M (2008) Immunotherapy for neurological disease. Clin Immunol 128:294–305PubMedCrossRef Villoslada P, Melero I, Pablus JL, Martino G, Ucelli A, Montalban Y, Avila J, Rivest S, Acarin L, Appel S, Khoury SJ, McGeer P, Ferrer I, Delgado M, Obeso J, Schwartz M (2008) Immunotherapy for neurological disease. Clin Immunol 128:294–305PubMedCrossRef
go back to reference Yaguchi M, Fujita Y, Amari M, Takatama M, Al-Sarraj S, Leigh PN, Okamoto K (2004) Morphological differences of intraneural ubiquitin positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology 24:296–301PubMedCrossRef Yaguchi M, Fujita Y, Amari M, Takatama M, Al-Sarraj S, Leigh PN, Okamoto K (2004) Morphological differences of intraneural ubiquitin positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology 24:296–301PubMedCrossRef
go back to reference Yamaguchi H, Nakazato Y, Shoji M, Okamoto K, Ihara Y, Morimatsu M, Hirai S (1991) Secondary deposition of beta amyloid within extracellular tangles in Alzheimer-type dementia. Am J Pathol 138:699–705PubMed Yamaguchi H, Nakazato Y, Shoji M, Okamoto K, Ihara Y, Morimatsu M, Hirai S (1991) Secondary deposition of beta amyloid within extracellular tangles in Alzheimer-type dementia. Am J Pathol 138:699–705PubMed
go back to reference Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561–575PubMedCrossRef Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561–575PubMedCrossRef
Metadata
Title
Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders
Authors
Richard A. Armstrong
Nigel J. Cairns
Publication date
01-12-2012
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 12/2012
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-012-0838-3

Other articles of this Issue 12/2012

Journal of Neural Transmission 12/2012 Go to the issue

Neurology and Preclinical Neurological Studies - Short communication

The history of the research of iron in parkinsonian substantia nigra

Neurology and Preclinical Neurological Studies - Review article

Iron accumulation in Parkinson’s disease

Basic Neurosciences, Genetics and Immunology - Original Article

Swainsonine as a lysosomal toxin affects dopaminergic neurons

Basic Neurosciences, Genetics and Immunology - Original Article

Extracts of Sideritis scardica as triple monoamine reuptake inhibitors

Psychiatry and Preclinical Psychiatric Studies - Rapid communication

Alcohol dependence in same-sex and opposite-sex twins